Consistently, we demonstrated that local administration of IL-15 in tumor mass directly modulates glioma microenvironment, re-boosting the immune response against tumor cells and activating the interaction between NK cells and microglia (11). This evidence concerns the gene IL15 and central nervous system cancer.